These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 25103845)

  • 61. Regulation of follicular dendritic cell networks by activated T cells: the role of CD137 signaling.
    Sun Y; Blink SE; Chen JH; Fu YX
    J Immunol; 2005 Jul; 175(2):884-90. PubMed ID: 16002686
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A lung-specific neo-antigen elicits specific CD8+ T cell tolerance with preserved CD4+ T cell reactivity. Implications for immune-mediated lung disease.
    Enelow RI; Stoler MH; Srikiatkhachorn A; Kerlakian C; Agersborg S; Whitsett JA; Braciale TJ
    J Clin Invest; 1996 Aug; 98(4):914-22. PubMed ID: 8770862
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.
    Wieland A; Shashidharamurthy R; Kamphorst AO; Han JH; Aubert RD; Choudhury BP; Stowell SR; Lee J; Punkosdy GA; Shlomchik MJ; Selvaraj P; Ahmed R
    Immunity; 2015 Feb; 42(2):367-378. PubMed ID: 25680276
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.
    Overwijk WW; Theoret MR; Finkelstein SE; Surman DR; de Jong LA; Vyth-Dreese FA; Dellemijn TA; Antony PA; Spiess PJ; Palmer DC; Heimann DM; Klebanoff CA; Yu Z; Hwang LN; Feigenbaum L; Kruisbeek AM; Rosenberg SA; Restifo NP
    J Exp Med; 2003 Aug; 198(4):569-80. PubMed ID: 12925674
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo.
    Fallarino F; Grohmann U; Bianchi R; Vacca C; Fioretti MC; Puccetti P
    J Immunol; 2000 Nov; 165(10):5495-501. PubMed ID: 11067902
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IL-2 intratumoral immunotherapy enhances CD8+ T cells that mediate destruction of tumor cells and tumor-associated vasculature: a novel mechanism for IL-2.
    Jackaman C; Bundell CS; Kinnear BF; Smith AM; Filion P; van Hagen D; Robinson BW; Nelson DJ
    J Immunol; 2003 Nov; 171(10):5051-63. PubMed ID: 14607902
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cross-recognition of a myelin peptide by CD8+ T cells in the CNS is not sufficient to promote neuronal damage.
    Reuter E; Gollan R; Grohmann N; Paterka M; Salmon H; Birkenstock J; Richers S; Leuenberger T; Brandt AU; Kuhlmann T; Zipp F; Siffrin V
    J Neurosci; 2015 Mar; 35(12):4837-50. PubMed ID: 25810515
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide.
    Grohmann U; Fioretti MC; Bianchi R; Belladonna ML; Ayroldi E; Surace D; Silla S; Puccetti P
    Crit Rev Immunol; 1998; 18(1-2):87-98. PubMed ID: 9419451
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice.
    Wang B; Zaidi N; He LZ; Zhang L; Kuroiwa JM; Keler T; Steinman RM
    Breast Cancer Res; 2012 Mar; 14(2):R39. PubMed ID: 22397502
    [TBL] [Abstract][Full Text] [Related]  

  • 72. CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.
    Price JD; Beauchamp NM; Rahir G; Zhao Y; Rieger CC; Lau-Kilby AW; Tarbell KV
    J Leukoc Biol; 2014 Feb; 95(2):325-36. PubMed ID: 24082013
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation.
    Krakowski ML; Owens T
    Eur J Immunol; 2000 Apr; 30(4):1002-9. PubMed ID: 10760787
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adoptive immunity in immune-deficient scid/scid mice. I. Differential requirements of naive and primed lymphocytes for CD4+ T cells during rejection of minor histocompatibility antigen-disparate skin grafts.
    Roopenian DC; Anderson PS
    Transplantation; 1988 Dec; 46(6):899-904. PubMed ID: 2905088
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand.
    Ray A; Basu S; Williams CB; Salzman NH; Dittel BN
    J Immunol; 2012 Apr; 188(7):3188-98. PubMed ID: 22368274
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Efficient priming of CD4+ and CD8+ T cells by DNA vaccination depends on appropriate targeting of sufficient levels of immunologically relevant antigen to appropriate processing pathways.
    Rush C; Mitchell T; Garside P
    J Immunol; 2002 Nov; 169(9):4951-60. PubMed ID: 12391208
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Immunological tolerance to muscle autoantigens involves peripheral deletion of autoreactive CD8+ T cells.
    Franck E; Bonneau C; Jean L; Henry JP; Lacoume Y; Salvetti A; Boyer O; Adriouch S
    PLoS One; 2012; 7(5):e36444. PubMed ID: 22570714
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Stimulation of the glucocorticoid-induced TNF receptor family-related receptor on CD8 T cells induces protective and high-avidity T cell responses to tumor-specific antigens.
    Côté AL; Zhang P; O'Sullivan JA; Jacobs VL; Clemis CR; Sakaguchi S; Guevara-Patiño JA; Turk MJ
    J Immunol; 2011 Jan; 186(1):275-83. PubMed ID: 21106849
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.
    Staveley-O'Carroll K; Schell TD; Jimenez M; Mylin LM; Tevethia MJ; Schoenberger SP; Tevethia SS
    J Immunol; 2003 Jul; 171(2):697-707. PubMed ID: 12847236
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
    Zhan Y; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.